Logo

molecular profiling

BostonGene, Little Warrior Foundation Partner to Develop Sarcoma-Specific Liquid Biopsy

Liquid biopsy tests will be designed to detect molecular alterations and fusions specific to sarcoma using cell-free DNA and RNA.

Synergy Oncology to Develop Tumor Profiling Test Using Sophia Genetics DDM Platform

Synergy will incorporate Sophia DDM to launch Totality, a tumor molecular profiling assay to help physicians match variants to therapies and clinical trials.

Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform

Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology.

Genomic Testing Cooperative Implementing AI, Molecular Profiling to Improve Cancer Diagnosis
Premium

In a recent paper, GTC and its partners validated their RNAnalysis and TraceWork algorithms for targeted transcriptome and clinical decision support.

BostonGene, Mass General Hospital Cancer Center Form Research Alliance

BostonGene will use its computational platform to find associations between tumor genetics, the immune system, and the effectiveness of new treatments.

Jul 12, 2022

BostonGene, Memorial Sloan Kettering Sign Cancer Precision Medicine Research Agreement

Jul 12, 2022

NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling

Apr 6, 2022

BostonGene Closes $150M Series B Funding Round

Dec 14, 2021

BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally

Sep 16, 2021

Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features

Feb 25, 2021

Natera Revenues Grow 35 Percent in Q4

Jan 29, 2021

4HF Biotec Banking on Multiomic Data Analysis to Help Pharma Find New Oncology Compounds
Premium

Nov 17, 2020

Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition

Nov 10, 2020

BostonGene, Thomas Jefferson University Partner on Head, Neck Cancer Research

Oct 14, 2020

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

Jun 15, 2020

Roswell Biotechnologies Enters Critical Phase of Industrializing Molecular Sensor Production
Premium

Jun 2, 2020

Evidence for Targeted Treatment Builds in Cancers of Unknown Primary but Randomized Data Pending
Premium

May 27, 2020

John Theurer Cancer Center, Genomic Testing Cooperative to Establish NGS Lab for Cancers

May 6, 2020

Pediatric Cancer Patients With Solid Tumors Have Many Druggable Germline Alterations

Nov 12, 2019

HTG Molecular Diagnostics Revenues Grow 15 Percent; Firm Lowers Full-Year Guidance

Jul 30, 2019

Illumina Says Population Sequencing, DTC Will Continue to Grow in the Long Term
Premium

Jul 23, 2019

BostonGene Partners With NIH on Clonal Evolution Study

Jul 12, 2019

Pathologists Face Hurdles in Supporting Precision Oncology, Seek Shared Decision Making
Premium

Apr 26, 2019

Inivata Clinical Validation Bolsters Liquid Biopsy Evidence Base, Aids Platform Comparisons
Premium

Apr 25, 2019

Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.